Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Zurawski

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Journal of Neuroimmunology|May 12, 2023
Familial Mediterranean Fever and multiple sclerosis treated with ocrelizumab: Case reportGiovanna S Manzano, Dylan R Rice, Jonathan Zurawski, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 2, 2018
Assessment of computer adaptive testing version of the Neuro-QOL for people with multiple sclerosisBrian C Healy, Jonathan Zurawski, Cindy T Gonzalez, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 13, 2019
7T MRI cerebral leptomeningeal enhancement is common in relapsing-remitting multiple sclerosis and is associated with cortical and thalamic lesionsJonathan Zurawski, Shahamat Tauhid, Renxin Chu, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 28, 2025
Change in serum neurofilament light chain and glial fibrillary acidic protein levels with high-efficacy and low-efficacy early therapy in multiple sclerosisEvan Madill, Vanessa Moreira Ferreira, Brian Healy, et al.
Journal of Neurology|September 6, 2024
The role of 7 T MRI to assess atrophy of the subcortical deep gray matter in relapsing-remitting multiple sclerosisAlexis M Callen, Jonathan Zurawski, Renxin Chu, et al.
Journal of the Neurological Sciences|December 8, 2022
Exploring the effect of glatiramer acetate on cerebral gray matter atrophy in multiple sclerosisMahmoud A AbdelRazek, Subhash Tummala, Fariha Khalid, et al.
Journal of the Neurological Sciences|June 18, 2019
The impact of cervical spinal cord atrophy on quality of life in multiple sclerosisJonathan Zurawski, Bonnie I Glanz, Brian C Healy, et al.
Multiple Sclerosis and Related Disorders|February 15, 2019
Time between expanded disability status scale (EDSS) scoresJonathan Zurawski, Bonnie I Glanz, Alicia Chua, et al.
Multiple Sclerosis and Related Disorders|February 3, 2020
Comparison of health-related quality of life across treatment groups in individuals with multiple sclerosisBonnie I Glanz, Jonathan Zurawski, Cindy T Gonzalez, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 28, 2021
The impact of ocrelizumab on health-related quality of life in individuals with multiple sclerosisBonnie I Glanz, Jonathan Zurawski, Emily C Casady, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Journal of Neuroimmunology|May 12, 2023
Familial Mediterranean Fever and multiple sclerosis treated with ocrelizumab: Case reportGiovanna S Manzano, Dylan R Rice, Jonathan Zurawski, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 2, 2018
Assessment of computer adaptive testing version of the Neuro-QOL for people with multiple sclerosisBrian C Healy, Jonathan Zurawski, Cindy T Gonzalez, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 13, 2019
7T MRI cerebral leptomeningeal enhancement is common in relapsing-remitting multiple sclerosis and is associated with cortical and thalamic lesionsJonathan Zurawski, Shahamat Tauhid, Renxin Chu, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 28, 2025
Change in serum neurofilament light chain and glial fibrillary acidic protein levels with high-efficacy and low-efficacy early therapy in multiple sclerosisEvan Madill, Vanessa Moreira Ferreira, Brian Healy, et al.
Journal of Neurology|September 6, 2024
The role of 7 T MRI to assess atrophy of the subcortical deep gray matter in relapsing-remitting multiple sclerosisAlexis M Callen, Jonathan Zurawski, Renxin Chu, et al.
Journal of the Neurological Sciences|December 8, 2022
Exploring the effect of glatiramer acetate on cerebral gray matter atrophy in multiple sclerosisMahmoud A AbdelRazek, Subhash Tummala, Fariha Khalid, et al.
Journal of the Neurological Sciences|June 18, 2019
The impact of cervical spinal cord atrophy on quality of life in multiple sclerosisJonathan Zurawski, Bonnie I Glanz, Brian C Healy, et al.
Multiple Sclerosis and Related Disorders|February 15, 2019
Time between expanded disability status scale (EDSS) scoresJonathan Zurawski, Bonnie I Glanz, Alicia Chua, et al.
Multiple Sclerosis and Related Disorders|February 3, 2020
Comparison of health-related quality of life across treatment groups in individuals with multiple sclerosisBonnie I Glanz, Jonathan Zurawski, Cindy T Gonzalez, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 28, 2021
The impact of ocrelizumab on health-related quality of life in individuals with multiple sclerosisBonnie I Glanz, Jonathan Zurawski, Emily C Casady, et al.
Pageof 4